DETROIT — Ford Motor on Monday will attempt to turn skeptics of its electric vehicle growth plans, which some Wall Street analysts have called “ambitious” and “crazy high,” into believers.
The Detroit automaker will host its capital markets day, during which it has promised to provide details of how Ford expects to achieve previously stated targets for 8% EBIT margin on its electric vehicle unit and a 2 million EV production runrate by 2026, up from an expected 600,000 by year-end.
“We will take you through why we believe that 8% margin is totally realistic despite all the pricing pressure that we will absolutely get because everyone wants to grow,” CEO Jim Farley said during the company’s first-quarter earnings call earlier this month.
The event is called “Delivering Ford+,” a reference to Farley’s turnaround and restructuring efforts that some have criticized for not being executed quickly enough. Farley announced the plan seven months into his tenure, in May 2021.
The automaker’s CEO described the capital markets day as an opportunity to demonstrate how the strategy is “coming to life.” The company is expected to run through its profit walks for its traditional “Ford Blue” and “Ford Pro” commercial businesses in addition to its “Model e” electric vehicle unit.
Ford also is expected to preview its second-generation battery products and technology, which the company has said will be crucial to achieving that 8% EBIT margin. The EV business is expected to lose about $3 billion this year.
Ford previously said it expects to hit that profit margin largely through scale, EV battery improvements and efficiencies in design and engineering.
“There’s definitely some analysts that are skeptical,” Morningstar analyst David Whiston told CNBC. “I think Monday is an opportunity to try and convince some of those skeptics that it can happen. I’m personally willing to give them the benefit of the doubt on that … you’ve got to win people over.”
Whiston described the timeline for the targets as “tight.” Others have been more critical.
Morgan Stanley analyst Adam Jonas during Ford’s first-quarter earnings call described the EV production increase as “crazy high.” Barclays analyst Dan Levy in a note to investors this week called it “ambitious.”
“Currently, we are skeptical as to Ford’s ability to meet both targets, as we expect it to opt for a balance of volumes with profit opportunities,” Levy said.
Analysts don’t expect much movement in the stock from the event, unless Ford surprises with a new product or change in previously announced plans.
“Overall, we think Ford’s key targets are unlikely to be different from its recent teach-in session, but management will attempt to give investors more comfort around them,” Deutsche Bank analyst Emmanuel Rosner said Wednesday in an investor note, reiterating the firm’s sell rating on the stock.
Ford stock is rated “hold” with an average target price of $13.63 per share, according to analyst ratings and estimates compiled by FactSet.
Shares of Ford are up by about 75% since Farley became CEO in October 2020. The stock closed Friday at $11.65 per share.
– CNBC’s Michael Bloom contributed to this report.
ivermectin pills – carbamazepine 400mg pill tegretol 200mg generic
accutane 10mg without prescription – order linezolid for sale zyvox generic
cheap amoxicillin online – purchase amoxicillin generic order combivent 100mcg pill
azithromycin price – tindamax 500mg over the counter order nebivolol 5mg online
brand omnacortil 10mg – buy azithromycin prometrium for sale
acticlate pills – glucotrol medication glucotrol for sale online
order semaglutide 14mg for sale – rybelsus uk order cyproheptadine online
order tizanidine pill – buy hydroxychloroquine 200mg without prescription buy hydrochlorothiazide online cheap
cialis professional – generic viagra 100mg brand viagra 100mg
sildenafil online buy – purchase viagra cialis 40mg
order atorvastatin 40mg generic – buy lisinopril 5mg for sale order zestril 2.5mg for sale
cenforce 100mg oral – order glucophage 1000mg online glycomet oral
buy prilosec pills – prilosec 10mg sale atenolol 100mg brand
buy medrol 8mg – buy methylprednisolone 4mg online buy aristocort without prescription
clarinex 5mg brand – claritin pill order dapoxetine 60mg pills
misoprostol 200mcg oral – buy generic misoprostol order diltiazem pill
order acyclovir 800mg generic – order rosuvastatin online rosuvastatin online buy
domperidone pills – buy cyclobenzaprine generic buy cheap cyclobenzaprine